Novo Nordisk shares jump 5% on promising weight loss trial results; Eli Lilly dips
March 07, 2024 at 06:22 AM EST
Novo Nordisk shares climbed 5% on Thursday morning after the Danish pharmaceutical giant reported positive early trial data for a new weight loss drug.